Your browser doesn't support javascript.
loading
The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.
Jansen, Willemijn J; Handels, Ron L H; Visser, Pieter Jelle; Aalten, Pauline; Bouwman, Femke; Claassen, Jurgen; van Domburg, Peter; Hoff, Erik; Hoogmoed, Jan; Leentjens, Albert F G; Rikkert, Marcel Olde; Oleksik, Ania M; Smid, Machiel; Scheltens, Philip; Wolfs, Claire; Verhey, Frans; Ramakers, Inez H G B.
Afiliação
  • Jansen WJ; Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Handels RL; Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Visser PJ; Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Aalten P; Department of Neurology, VUmc Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands.
  • Bouwman F; Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Claassen J; Department of Neurology, VUmc Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands.
  • van Domburg P; Department of Geriatrics, Radboud Alzheimer Center, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Hoff E; Department of Neurology, Zuyderland Medical Center, Sittard, The Netherlands.
  • Hoogmoed J; Department of Neurology, Zuyderland Medical Center, Heerlen, The Netherlands.
  • Leentjens AF; Department of Geriatrics, Laurentius Hospital, Roermond, The Netherlands.
  • Rikkert MO; Department of Geriatrics, St. Jans Gasthuis, Weert, The Netherlands.
  • Oleksik AM; Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Smid M; Department of Geriatrics, Radboud Alzheimer Center, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Scheltens P; Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Wolfs C; Department of Geriatrics, Zuyderland Medical Center, Sittard, The Netherlands.
  • Verhey F; Department of Neurology, VUmc Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands.
  • Ramakers IH; Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
J Alzheimers Dis ; 55(2): 679-689, 2017.
Article em En | MEDLINE | ID: mdl-27716658
BACKGROUND: Neuropsychological testing has long been embedded in daily clinical practice at memory clinics but the added value of a complete neuropsychological assessment (NPA) to standard clinical evaluation is unknown. OBJECTIVE: To evaluate the added diagnostic and prognostic value of NPA to clinical evaluation only in memory clinic patients. METHODS: In 221 memory clinic patients of a prospective cohort study, clinical experts diagnosed clinical syndrome (subjective cognitive impairment (SCI), mild cognitive impairment (MCI), or dementia) and etiology (Alzheimer's disease (AD) or no AD), and provided a prognosis of disease course (decline or no decline) before and after results of NPA were made available. The reference standard was a panel consensus based on all clinical information at baseline and up to 2 follow-up assessments. RESULTS: With NPA data available, clinicians changed their initial syndromal diagnosis in 22% of patients, and the etiological diagnosis as well as the prognosis in 15%. This led to an increase in correctly classified cases of 18% for syndromal diagnosis, 5% for etiological diagnosis, and 1% for prognosis. NPA data resulted in the largest improvement in patients initially classified as SCI (syndrome: 93.3% (n = 14) correctly reclassified, etiology: net reclassification improvement [NRI] = 0.61, prognosis: NRI = 0.13) or MCI (syndrome: 89.3% (n = 23) correctly reclassified, etiology: NRI = 0.17, prognosis: NRI = 0.14), while there was no improvement in patients with dementia (syndrome: 100% (n = 1) correctly reclassified, etiology: NRI = -0.05, prognosis: NRI = -0.06). Overall, inclusion of NPA in the diagnostic process increased confidence in all diagnoses with 6-7%. CONCLUSION: Administration of a complete NPA after standard clinical evaluation has added value for diagnosing cognitive syndrome and its underlying etiology in patients regarded as non-demented based on the first clinical impression.
Assuntos
Palavras-chave
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos da Memória / Testes Neuropsicológicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Alzheimers Dis Ano de publicação: 2017 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos da Memória / Testes Neuropsicológicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Alzheimers Dis Ano de publicação: 2017 Tipo de documento: Article